Novel motif:2: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif2_GCTGGAGG
|novel_motifs_human_sample_pval=11376-118A8_11051;0.746696,11327-117E4_11969;0.785443,11473-119C6_11054;0.211541,11474-119C7_12067;0.5630...") |
No edit summary |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:29, 9 September 2013
name: | motif2_GCTGGAGG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 8.290525e-14 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 4.182512e-12 |
GO:0060033 | anatomical structure regression | 2.589211e-11 |
GO:0010984 | regulation of lipoprotein particle clearance | 4.355080e-11 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 6.285619e-11 |
GO:0035814 | negative regulation of renal sodium excretion | 6.291177e-11 |
GO:0010625 | positive regulation of Schwann cell proliferation | 7.766284e-11 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 4.623185e-10 |
GO:0050902 | leukocyte adhesive activation | 4.623185e-10 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 4.722854e-10 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 1.086347e-9 |
GO:0008078 | mesodermal cell migration | 2.695714e-9 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 5.564215e-9 |
GO:0010624 | regulation of Schwann cell proliferation | 8.337830e-9 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 9.835837e-9 |
GO:0043491 | protein kinase B signaling cascade | 1.826353e-8 |
GO:0003009 | skeletal muscle contraction | 2.279822e-8 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 4.832481e-8 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 5.541944e-8 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 7.381499e-8 |
GO:0032933 | SREBP-mediated signaling pathway | 7.480128e-8 |
GO:0006884 | cell volume homeostasis | 7.946269e-8 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 8.136397e-8 |
GO:0034505 | tooth mineralization | 1.049544e-7 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.147274e-7 |
GO:0043206 | fibril organization | 1.245255e-7 |
GO:0007522 | visceral muscle development | 1.854908e-7 |
GO:0046626 | regulation of insulin receptor signaling pathway | 2.495430e-7 |
GO:0019048 | virus-host interaction | 3.268683e-7 |
GO:0060251 | regulation of glial cell proliferation | 3.724807e-7 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 3.789286e-7 |
GO:0032964 | collagen biosynthetic process | 4.188880e-7 |
GO:0002268 | follicular dendritic cell differentiation | 5.139985e-7 |
GO:0042074 | cell migration involved in gastrulation | 5.302732e-7 |
GO:0006349 | regulation of gene expression by genetic imprinting | 5.454143e-7 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 5.592006e-7 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 8.289140e-7 |
GO:0040040 | thermosensory behavior | 8.586765e-7 |
GO:0003062 | regulation of heart rate by chemical signal | 1.089680e-6 |
GO:0010821 | regulation of mitochondrion organization | 1.194993e-6 |
GO:0050779 | RNA destabilization | 1.198558e-6 |
GO:0001880 | Mullerian duct regression | 1.334187e-6 |
GO:0006544 | glycine metabolic process | 1.373367e-6 |
GO:0060349 | bone morphogenesis | 1.440675e-6 |
GO:0045908 | negative regulation of vasodilation | 1.442388e-6 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.451250e-6 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 1.611889e-6 |
GO:0006706 | steroid catabolic process | 1.979142e-6 |
GO:0007509 | mesoderm migration involved in gastrulation | 2.171464e-6 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 2.398097e-6 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 2.466475e-6 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 2.716998e-6 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 2.806131e-6 |
GO:0030225 | macrophage differentiation | 2.993157e-6 |
GO:0002315 | marginal zone B cell differentiation | 3.976414e-6 |
GO:0045064 | T-helper 2 cell differentiation | 3.976414e-6 |
GO:0006261 | DNA-dependent DNA replication | 4.011697e-6 |
GO:0060348 | bone development | 4.087904e-6 |
GO:0045109 | intermediate filament organization | 4.590602e-6 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 5.778834e-6 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 6.380024e-6 |
GO:0002906 | negative regulation of mature B cell apoptosis | 6.380024e-6 |
GO:0006853 | carnitine shuttle | 6.500280e-6 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 6.669172e-6 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 7.762429e-6 |
GO:0046339 | diacylglycerol metabolic process | 7.958857e-6 |
GO:0015816 | glycine transport | 8.822820e-6 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 9.217380e-6 |
GO:0043542 | endothelial cell migration | 9.757247e-6 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 9.984127e-6 |
GO:0046314 | phosphocreatine biosynthetic process | 1.045866e-5 |
GO:0030198 | extracellular matrix organization | 1.147761e-5 |
GO:0030851 | granulocyte differentiation | 1.262099e-5 |
GO:0006707 | cholesterol catabolic process | 1.270143e-5 |
GO:0090311 | regulation of protein deacetylation | 1.304156e-5 |
GO:0035811 | negative regulation of urine volume | 1.314227e-5 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.373238e-5 |
GO:0031063 | regulation of histone deacetylation | 1.440046e-5 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.448955e-5 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 1.610569e-5 |
GO:0048548 | regulation of pinocytosis | 1.629265e-5 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.631323e-5 |
GO:0034224 | cellular response to zinc ion starvation | 1.663944e-5 |
GO:0060669 | embryonic placenta morphogenesis | 1.706800e-5 |
GO:0060350 | endochondral bone morphogenesis | 1.767654e-5 |
GO:0060252 | positive regulation of glial cell proliferation | 1.770258e-5 |
GO:0035094 | response to nicotine | 1.775822e-5 |
GO:0030046 | parallel actin filament bundle assembly | 1.793640e-5 |
GO:0045906 | negative regulation of vasoconstriction | 1.849835e-5 |
GO:0044062 | regulation of excretion | 1.907579e-5 |
GO:0043462 | regulation of ATPase activity | 1.937959e-5 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 1.945276e-5 |
GO:0044236 | multicellular organismal metabolic process | 2.120026e-5 |
GO:0019087 | transformation of host cell by virus | 2.135310e-5 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 2.143177e-5 |
GO:0033505 | floor plate morphogenesis | 2.228478e-5 |
GO:0022038 | corpus callosum development | 2.355615e-5 |
GO:0018205 | peptidyl-lysine modification | 2.441273e-5 |
GO:0043534 | blood vessel endothelial cell migration | 2.512377e-5 |
GO:0048705 | skeletal system morphogenesis | 2.520898e-5 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 2.589246e-5 |
GO:0043304 | regulation of mast cell degranulation | 2.774836e-5 |
GO:0032863 | activation of Rac GTPase activity | 2.820118e-5 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 2.823477e-5 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 2.845809e-5 |
GO:0045794 | negative regulation of cell volume | 2.891639e-5 |
GO:0019388 | galactose catabolic process | 2.933844e-5 |
GO:0009070 | serine family amino acid biosynthetic process | 2.952824e-5 |
GO:0002071 | glandular epithelial cell maturation | 3.066535e-5 |
GO:0033235 | positive regulation of protein sumoylation | 3.093410e-5 |
GO:0060124 | positive regulation of growth hormone secretion | 3.137851e-5 |
GO:0070256 | negative regulation of mucus secretion | 3.174028e-5 |
GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep | 3.174028e-5 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 3.212570e-5 |
GO:0043300 | regulation of leukocyte degranulation | 3.303833e-5 |
GO:0043088 | regulation of Cdc42 GTPase activity | 3.379826e-5 |
GO:0060073 | micturition | 3.412679e-5 |
GO:0048627 | myoblast development | 3.445961e-5 |
GO:0001909 | leukocyte mediated cytotoxicity | 3.499256e-5 |
GO:0060346 | bone trabecula formation | 3.899215e-5 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 3.905833e-5 |
GO:0060020 | Bergmann glial cell differentiation | 3.907661e-5 |
GO:0071732 | cellular response to nitric oxide | 3.965025e-5 |
GO:0006475 | internal protein amino acid acetylation | 4.042202e-5 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 4.136803e-5 |
GO:0060670 | branching involved in embryonic placenta morphogenesis | 4.148651e-5 |
GO:0006012 | galactose metabolic process | 4.239362e-5 |
GO:0071071 | regulation of phospholipid biosynthetic process | 4.351959e-5 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 4.423528e-5 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 4.445383e-5 |
GO:0070875 | positive regulation of glycogen metabolic process | 4.523309e-5 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 4.618331e-5 |
GO:0044243 | multicellular organismal catabolic process | 4.748613e-5 |
GO:0002017 | regulation of blood volume by renal aldosterone | 4.971523e-5 |
GO:0051013 | microtubule severing | 4.998929e-5 |
GO:0019064 | viral envelope fusion with host membrane | 4.998929e-5 |
GO:0031017 | exocrine pancreas development | 5.045493e-5 |
GO:0018277 | protein deamination | 5.420844e-5 |
GO:0006353 | transcription termination, DNA-dependent | 5.426616e-5 |
GO:0034969 | histone arginine methylation | 5.695428e-5 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 5.886003e-5 |
GO:0014848 | urinary tract smooth muscle contraction | 5.894625e-5 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 6.265631e-5 |
GO:0070327 | thyroid hormone transport | 6.316286e-5 |
GO:0005979 | regulation of glycogen biosynthetic process | 6.401879e-5 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 6.481718e-5 |
GO:0015695 | organic cation transport | 6.755928e-5 |
GO:0002432 | granuloma formation | 6.863369e-5 |
GO:0032012 | regulation of ARF protein signal transduction | 7.164261e-5 |
GO:0032963 | collagen metabolic process | 7.172445e-5 |
GO:0043487 | regulation of RNA stability | 7.276667e-5 |
GO:0018393 | internal peptidyl-lysine acetylation | 7.781185e-5 |
GO:0006545 | glycine biosynthetic process | 7.873351e-5 |
GO:0032526 | response to retinoic acid | 7.876315e-5 |
GO:0071316 | cellular response to nicotine | 7.987597e-5 |
GO:0071514 | genetic imprinting | 8.179285e-5 |
GO:0090200 | positive regulation of release of cytochrome c from mitochondria | 8.266279e-5 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 8.303033e-5 |
GO:0006083 | acetate metabolic process | 8.303033e-5 |
GO:0090102 | cochlea development | 8.410720e-5 |
GO:0050746 | regulation of lipoprotein metabolic process | 8.442162e-5 |
GO:0033233 | regulation of protein sumoylation | 8.503181e-5 |
GO:0072337 | modified amino acid transport | 9.038259e-5 |
GO:0051956 | negative regulation of amino acid transport | 9.189024e-5 |
GO:0046814 | virion attachment, binding of host cell surface coreceptor | 9.230340e-5 |
GO:0043543 | protein acylation | 9.379014e-5 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 9.439542e-5 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 9.804416e-5 |
GO:0006473 | protein acetylation | 1.000298e-4 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 1.036241e-4 |
GO:0061144 | alveolar secondary septum development | 1.041502e-4 |
GO:0018394 | peptidyl-lysine acetylation | 1.062318e-4 |
GO:0035313 | wound healing, spreading of epidermal cells | 1.071553e-4 |
GO:0000022 | mitotic spindle elongation | 1.113703e-4 |
GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process | 1.113703e-4 |
GO:0002636 | positive regulation of germinal center formation | 1.123739e-4 |
GO:0000302 | response to reactive oxygen species | 1.152972e-4 |
GO:0007020 | microtubule nucleation | 1.168899e-4 |
GO:0045932 | negative regulation of muscle contraction | 1.216087e-4 |
GO:0048703 | embryonic viscerocranium morphogenesis | 1.226757e-4 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 1.243825e-4 |
GO:0043303 | mast cell degranulation | 1.246192e-4 |
GO:0001957 | intramembranous ossification | 1.256428e-4 |
GO:0060872 | semicircular canal development | 1.262878e-4 |
GO:0010822 | positive regulation of mitochondrion organization | 1.276908e-4 |
GO:0015696 | ammonium transport | 1.289013e-4 |
GO:0055093 | response to hyperoxia | 1.409607e-4 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.469874e-4 |
GO:0010896 | regulation of triglyceride catabolic process | 1.486425e-4 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 1.490739e-4 |
GO:0015879 | carnitine transport | 1.532897e-4 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 1.566594e-4 |
GO:0010897 | negative regulation of triglyceride catabolic process | 1.566594e-4 |
GO:0009264 | deoxyribonucleotide catabolic process | 1.567066e-4 |
GO:0046730 | induction of host immune response by virus | 1.643184e-4 |
GO:0032006 | regulation of TOR signaling cascade | 1.692584e-4 |
GO:0051546 | keratinocyte migration | 1.746911e-4 |
GO:0022617 | extracellular matrix disassembly | 1.764259e-4 |
GO:0060711 | labyrinthine layer development | 1.782011e-4 |
GO:0035470 | positive regulation of vascular wound healing | 1.799692e-4 |
GO:0015747 | urate transport | 1.799692e-4 |
GO:0042396 | phosphagen biosynthetic process | 1.826708e-4 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 1.919391e-4 |
GO:0035499 | carnosine biosynthetic process | 1.919391e-4 |
GO:0002385 | mucosal immune response | 1.922945e-4 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 2.049130e-4 |
GO:0006289 | nucleotide-excision repair | 2.163281e-4 |
GO:0021508 | floor plate formation | 2.170435e-4 |
GO:0048549 | positive regulation of pinocytosis | 2.170435e-4 |
GO:0070873 | regulation of glycogen metabolic process | 2.172931e-4 |
GO:0051591 | response to cAMP | 2.188269e-4 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 2.197163e-4 |
GO:0043314 | negative regulation of neutrophil degranulation | 2.198545e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 2.264644e-4 |
GO:0071242 | cellular response to ammonium ion | 2.264644e-4 |
GO:0001977 | renal system process involved in regulation of blood volume | 2.277851e-4 |
GO:0035813 | regulation of renal sodium excretion | 2.298726e-4 |
GO:0044319 | wound healing, spreading of cells | 2.394166e-4 |
GO:0060343 | trabecula formation | 2.417252e-4 |
GO:0090103 | cochlea morphogenesis | 2.430441e-4 |
GO:0031330 | negative regulation of cellular catabolic process | 2.449316e-4 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 2.462045e-4 |
GO:0050965 | detection of temperature stimulus involved in sensory perception of pain | 2.472364e-4 |
GO:0006268 | DNA unwinding involved in replication | 2.485411e-4 |
GO:0003084 | positive regulation of systemic arterial blood pressure | 2.507807e-4 |
GO:0071394 | cellular response to testosterone stimulus | 2.649494e-4 |
GO:0070345 | negative regulation of fat cell proliferation | 2.702236e-4 |
GO:0071300 | cellular response to retinoic acid | 2.704430e-4 |
GO:0061038 | uterus morphogenesis | 2.859857e-4 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 2.863244e-4 |
GO:0048242 | epinephrine secretion | 2.895368e-4 |
GO:0045575 | basophil activation | 2.962080e-4 |
GO:0001694 | histamine biosynthetic process | 2.962080e-4 |
GO:0035854 | eosinophil fate commitment | 3.007002e-4 |
GO:0030222 | eosinophil differentiation | 3.007002e-4 |
GO:0090263 | positive regulation of canonical Wnt receptor signaling pathway | 3.026613e-4 |
GO:0045217 | cell-cell junction maintenance | 3.040498e-4 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 3.040734e-4 |
GO:0014832 | urinary bladder smooth muscle contraction | 3.090949e-4 |
GO:0090312 | positive regulation of protein deacetylation | 3.239871e-4 |
GO:0015939 | pantothenate metabolic process | 3.260484e-4 |
GO:0045940 | positive regulation of steroid metabolic process | 3.279247e-4 |
GO:0045655 | regulation of monocyte differentiation | 3.313552e-4 |
GO:0001300 | chronological cell aging | 3.334652e-4 |
GO:0045657 | positive regulation of monocyte differentiation | 3.428489e-4 |
GO:0043985 | histone H4-R3 methylation | 3.455334e-4 |
GO:0001546 | preantral ovarian follicle growth | 3.537241e-4 |
GO:0035732 | nitric oxide storage | 3.537241e-4 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 3.537241e-4 |
GO:0035726 | common myeloid progenitor cell proliferation | 3.537241e-4 |
GO:0031065 | positive regulation of histone deacetylation | 3.612537e-4 |
GO:0060014 | granulosa cell differentiation | 3.651695e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 3.667405e-4 |
GO:0006458 | 'de novo' protein folding | 3.676541e-4 |
GO:0002678 | positive regulation of chronic inflammatory response | 3.716364e-4 |
GO:0003229 | ventricular cardiac muscle tissue development | 3.726389e-4 |
GO:0046732 | active induction of host immune response by virus | 3.750114e-4 |
GO:0048708 | astrocyte differentiation | 3.781844e-4 |
GO:2000273 | positive regulation of receptor activity | 4.070064e-4 |
GO:0002448 | mast cell mediated immunity | 4.108603e-4 |
GO:0032425 | positive regulation of mismatch repair | 4.312923e-4 |
GO:0021562 | vestibulocochlear nerve development | 4.312923e-4 |
GO:0002443 | leukocyte mediated immunity | 4.359967e-4 |
GO:0000422 | mitochondrion degradation | 4.390698e-4 |
GO:0061304 | retinal blood vessel morphogenesis | 4.431734e-4 |
GO:0050861 | positive regulation of B cell receptor signaling pathway | 4.463763e-4 |
GO:0002426 | immunoglobulin production in mucosal tissue | 4.527987e-4 |
GO:0032793 | positive regulation of CREB transcription factor activity | 4.542474e-4 |
GO:0061370 | testosterone biosynthetic process | 4.636116e-4 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 4.636116e-4 |
GO:0050756 | fractalkine metabolic process | 4.636116e-4 |
GO:0033595 | response to genistein | 4.636116e-4 |
GO:0033006 | regulation of mast cell activation involved in immune response | 4.677240e-4 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 4.720232e-4 |
GO:0007028 | cytoplasm organization | 4.857908e-4 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 4.883283e-4 |
GO:0032796 | uropod organization | 4.991365e-4 |
GO:0040015 | negative regulation of multicellular organism growth | 5.233141e-4 |
GO:0000084 | S phase of mitotic cell cycle | 5.294156e-4 |
GO:0046110 | xanthine metabolic process | 5.366834e-4 |
GO:0015858 | nucleoside transport | 5.398522e-4 |
GO:0002921 | negative regulation of humoral immune response | 5.440429e-4 |
GO:0043585 | nose morphogenesis | 5.467648e-4 |
GO:0043353 | enucleate erythrocyte differentiation | 5.483715e-4 |
GO:0006354 | transcription elongation, DNA-dependent | 5.534592e-4 |
GO:0090205 | positive regulation of cholesterol metabolic process | 5.551333e-4 |
GO:0002026 | regulation of the force of heart contraction | 5.756715e-4 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 5.839312e-4 |
GO:0031365 | N-terminal protein amino acid modification | 5.950815e-4 |
GO:0046718 | entry of virus into host cell | 6.027952e-4 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 6.028748e-4 |
GO:0061383 | trabecula morphogenesis | 6.057120e-4 |
GO:0006423 | cysteinyl-tRNA aminoacylation | 6.071512e-4 |
GO:0070943 | neutrophil mediated killing of symbiont cell | 6.261819e-4 |
GO:0044258 | intestinal lipid catabolic process | 6.380331e-4 |
GO:0018350 | protein esterification | 6.380331e-4 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 6.380331e-4 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 6.416023e-4 |
GO:0001560 | regulation of cell growth by extracellular stimulus | 6.463325e-4 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 6.498817e-4 |
GO:0048382 | mesendoderm development | 6.498817e-4 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 6.518744e-4 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 6.518744e-4 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 6.518744e-4 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 6.534028e-4 |
GO:0045948 | positive regulation of translational initiation | 6.545106e-4 |
GO:0043313 | regulation of neutrophil degranulation | 6.546162e-4 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 6.594737e-4 |
GO:0007288 | sperm axoneme assembly | 6.835464e-4 |
GO:0014002 | astrocyte development | 6.939723e-4 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 6.949872e-4 |
GO:0016573 | histone acetylation | 6.961387e-4 |
GO:0051298 | centrosome duplication | 7.060467e-4 |
GO:0031668 | cellular response to extracellular stimulus | 7.113327e-4 |
GO:0060707 | trophoblast giant cell differentiation | 7.227945e-4 |
GO:0060215 | primitive hemopoiesis | 7.265923e-4 |
GO:0050434 | positive regulation of viral transcription | 7.323097e-4 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 7.405408e-4 |
GO:0023019 | signal transduction involved in regulation of gene expression | 7.442250e-4 |
GO:0061143 | alveolar primary septum development | 7.488866e-4 |
GO:0044342 | type B pancreatic cell proliferation | 7.488866e-4 |
GO:0014053 | negative regulation of gamma-aminobutyric acid secretion | 7.488866e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 7.488866e-4 |
GO:0006449 | regulation of translational termination | 7.498258e-4 |
GO:0002679 | respiratory burst involved in defense response | 7.808986e-4 |
GO:0032008 | positive regulation of TOR signaling cascade | 7.862009e-4 |
GO:0035247 | peptidyl-arginine omega-N-methylation | 7.971714e-4 |
GO:0035573 | N-terminal peptidyl-serine trimethylation | 8.009578e-4 |
GO:0035572 | N-terminal peptidyl-serine dimethylation | 8.009578e-4 |
GO:0018012 | N-terminal peptidyl-alanine trimethylation | 8.009578e-4 |
GO:0018016 | N-terminal peptidyl-proline dimethylation | 8.009578e-4 |
GO:0061157 | mRNA destabilization | 8.186957e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 8.186957e-4 |
GO:0051693 | actin filament capping | 8.338417e-4 |
GO:0033590 | response to cobalamin | 8.373752e-4 |
GO:0006117 | acetaldehyde metabolic process | 8.373752e-4 |
GO:0006342 | chromatin silencing | 8.471376e-4 |
GO:0048320 | axial mesoderm formation | 8.498768e-4 |
GO:0060620 | regulation of cholesterol import | 8.498768e-4 |
GO:0002513 | tolerance induction to self antigen | 8.514871e-4 |
GO:0043299 | leukocyte degranulation | 8.596481e-4 |
GO:0090207 | regulation of triglyceride metabolic process | 8.747442e-4 |
GO:0051017 | actin filament bundle assembly | 8.757860e-4 |
GO:0051788 | response to misfolded protein | 8.781383e-4 |
GO:0060621 | negative regulation of cholesterol import | 8.888903e-4 |
GO:0032321 | positive regulation of Rho GTPase activity | 8.891255e-4 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 8.936637e-4 |
GO:0051340 | regulation of ligase activity | 8.943122e-4 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 9.051173e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 9.224014e-4 |
GO:0006285 | base-excision repair, AP site formation | 9.272464e-4 |
GO:0032383 | regulation of intracellular cholesterol transport | 9.456187e-4 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 9.456187e-4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 9.603548e-4 |
GO:0090085 | regulation of protein deubiquitination | 9.633807e-4 |
GO:0018208 | peptidyl-proline modification | 9.751159e-4 |
GO:0030221 | basophil differentiation | 9.868828e-4 |
GO:0046655 | folic acid metabolic process | 1.008992e-3 |
GO:0001941 | postsynaptic membrane organization | 1.008992e-3 |
GO:0032862 | activation of Rho GTPase activity | 1.055001e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 1.057544e-3 |
GO:0046006 | regulation of activated T cell proliferation | 1.064674e-3 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.100480e-3 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 1.112536e-3 |
GO:0002579 | positive regulation of antigen processing and presentation | 1.118841e-3 |
GO:0060083 | smooth muscle contraction involved in micturition | 1.126450e-3 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 1.126450e-3 |
GO:0000093 | mitotic telophase | 1.136091e-3 |
GO:0035095 | behavioral response to nicotine | 1.146344e-3 |
GO:0048255 | mRNA stabilization | 1.163808e-3 |
GO:0035364 | thymine transport | 1.201327e-3 |
GO:0035344 | hypoxanthine transport | 1.201327e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 1.201327e-3 |
GO:0015854 | guanine transport | 1.201327e-3 |
GO:0007271 | synaptic transmission, cholinergic | 1.203884e-3 |
GO:0007172 | signal complex assembly | 1.213369e-3 |
GO:0032312 | regulation of ARF GTPase activity | 1.216394e-3 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.230706e-3 |
GO:0010742 | macrophage derived foam cell differentiation | 1.235774e-3 |
GO:0030574 | collagen catabolic process | 1.240036e-3 |
GO:0060219 | camera-type eye photoreceptor cell differentiation | 1.240802e-3 |
GO:0042335 | cuticle development | 1.250634e-3 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 1.250634e-3 |
GO:0032417 | positive regulation of sodium:hydrogen antiporter activity | 1.299170e-3 |
GO:0031536 | positive regulation of exit from mitosis | 1.302259e-3 |
GO:0043488 | regulation of mRNA stability | 1.335300e-3 |
GO:0032423 | regulation of mismatch repair | 1.366309e-3 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.366309e-3 |
GO:0007296 | vitellogenesis | 1.369680e-3 |
GO:0060713 | labyrinthine layer morphogenesis | 1.374854e-3 |
GO:0031284 | positive regulation of guanylate cyclase activity | 1.379671e-3 |
GO:0015742 | alpha-ketoglutarate transport | 1.379671e-3 |
GO:0031670 | cellular response to nutrient | 1.385572e-3 |
GO:0090150 | establishment of protein localization in membrane | 1.391050e-3 |
GO:0048733 | sebaceous gland development | 1.419853e-3 |
GO:0097107 | postsynaptic density assembly | 1.420983e-3 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 1.420983e-3 |
GO:0032786 | positive regulation of transcription elongation, DNA-dependent | 1.455132e-3 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1.488578e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 1.488578e-3 |
GO:0010288 | response to lead ion | 1.497498e-3 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.529664e-3 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 1.538934e-3 |
GO:0000216 | M/G1 transition of mitotic cell cycle | 1.566524e-3 |
GO:0050881 | musculoskeletal movement | 1.579101e-3 |
GO:0033037 | polysaccharide localization | 1.607822e-3 |
GO:0032462 | regulation of protein homooligomerization | 1.668611e-3 |
GO:0071956 | cellular component maintenance at cellular level | 1.677313e-3 |
GO:0003416 | endochondral bone growth | 1.677313e-3 |
GO:0030206 | chondroitin sulfate biosynthetic process | 1.685944e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.687633e-3 |
GO:0000132 | establishment of mitotic spindle orientation | 1.733125e-3 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 1.741402e-3 |
GO:0022616 | DNA strand elongation | 1.741402e-3 |
GO:0030007 | cellular potassium ion homeostasis | 1.757690e-3 |
GO:0045112 | integrin biosynthetic process | 1.778952e-3 |
GO:0006560 | proline metabolic process | 1.778952e-3 |
GO:0090130 | tissue migration | 1.779616e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 1.791609e-3 |
GO:0071731 | response to nitric oxide | 1.806787e-3 |
GO:0007184 | SMAD protein import into nucleus | 1.806787e-3 |
GO:0070489 | T cell aggregation | 1.843447e-3 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 1.880441e-3 |
GO:0021526 | medial motor column neuron differentiation | 1.896653e-3 |
GO:0043306 | positive regulation of mast cell degranulation | 1.915651e-3 |
GO:0007044 | cell-substrate junction assembly | 1.926611e-3 |
GO:0009253 | peptidoglycan catabolic process | 1.983988e-3 |
GO:0061205 | paramesonephric duct development | 1.983988e-3 |
GO:0009651 | response to salt stress | 1.991658e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 2.017070e-3 |
GO:0048752 | semicircular canal morphogenesis | 2.025566e-3 |
GO:0010225 | response to UV-C | 2.050447e-3 |
GO:0007506 | gonadal mesoderm development | 2.055436e-3 |
GO:0016048 | detection of temperature stimulus | 2.056751e-3 |
GO:0060169 | negative regulation of adenosine receptor signaling pathway | 2.077966e-3 |
GO:0060407 | negative regulation of penile erection | 2.077966e-3 |
GO:0002314 | germinal center B cell differentiation | 2.077966e-3 |
GO:0046111 | xanthine biosynthetic process | 2.077966e-3 |
GO:0046061 | dATP catabolic process | 2.077966e-3 |
GO:0006157 | deoxyadenosine catabolic process | 2.077966e-3 |
GO:0001829 | trophectodermal cell differentiation | 2.079424e-3 |
GO:0060179 | male mating behavior | 2.090258e-3 |
GO:2000188 | regulation of cholesterol homeostasis | 2.090258e-3 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 2.090258e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 2.168831e-3 |
GO:0050872 | white fat cell differentiation | 2.213279e-3 |
GO:0071299 | cellular response to vitamin A | 2.246670e-3 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 2.272622e-3 |
GO:0042267 | natural killer cell mediated cytotoxicity | 2.276620e-3 |
GO:0002676 | regulation of chronic inflammatory response | 2.298351e-3 |
GO:0016032 | viral reproduction | 2.366827e-3 |
GO:0045806 | negative regulation of endocytosis | 2.369319e-3 |
GO:0060956 | endocardial cell differentiation | 2.376495e-3 |
GO:0061302 | smooth muscle cell-matrix adhesion | 2.456929e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 2.456929e-3 |
GO:0046607 | positive regulation of centrosome cycle | 2.456929e-3 |
GO:0035845 | photoreceptor cell outer segment organization | 2.456929e-3 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 2.475662e-3 |
GO:0032464 | positive regulation of protein homooligomerization | 2.483968e-3 |
GO:0070309 | lens fiber cell morphogenesis | 2.523255e-3 |
GO:0071874 | cellular response to norepinephrine stimulus | 2.563948e-3 |
GO:0060084 | synaptic transmission involved in micturition | 2.563948e-3 |
GO:0003105 | negative regulation of glomerular filtration | 2.563948e-3 |
GO:0070483 | detection of hypoxia | 2.609357e-3 |
GO:0019318 | hexose metabolic process | 2.637861e-3 |
GO:0009069 | serine family amino acid metabolic process | 2.638156e-3 |
GO:0051645 | Golgi localization | 2.696315e-3 |
GO:0051365 | cellular response to potassium ion starvation | 2.696315e-3 |
GO:0021570 | rhombomere 4 development | 2.696315e-3 |
GO:0006097 | glyoxylate cycle | 2.696315e-3 |
GO:0030157 | pancreatic juice secretion | 2.779386e-3 |
GO:0032319 | regulation of Rho GTPase activity | 2.792772e-3 |
GO:0033504 | floor plate development | 2.801959e-3 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 2.826997e-3 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 2.832342e-3 |
GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation | 2.885541e-3 |
GO:0042104 | positive regulation of activated T cell proliferation | 2.917188e-3 |
GO:0009304 | tRNA transcription | 2.945185e-3 |
GO:0071496 | cellular response to external stimulus | 2.952094e-3 |
GO:0072011 | glomerular endothelium development | 3.069703e-3 |
GO:0072144 | glomerular mesangial cell development | 3.069703e-3 |
GO:0060035 | notochord cell development | 3.069703e-3 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 3.079672e-3 |
GO:0015809 | arginine transport | 3.111939e-3 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 3.126813e-3 |
GO:0060123 | regulation of growth hormone secretion | 3.139038e-3 |
GO:0015862 | uridine transport | 3.142298e-3 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 3.146351e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 3.152115e-3 |
GO:0046533 | negative regulation of photoreceptor cell differentiation | 3.219719e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 3.304449e-3 |
GO:0016056 | rhodopsin mediated signaling pathway | 3.310853e-3 |
GO:0006013 | mannose metabolic process | 3.391722e-3 |
GO:0060998 | regulation of dendritic spine development | 3.410019e-3 |
GO:0071392 | cellular response to estradiol stimulus | 3.455444e-3 |
GO:0042093 | T-helper cell differentiation | 3.455444e-3 |
GO:0031297 | replication fork processing | 3.519029e-3 |
GO:0033601 | positive regulation of mammary gland epithelial cell proliferation | 3.519029e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 3.559944e-3 |
GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity | 3.598637e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0060192 | negative regulation of lipase activity | 7.771046e-10 |
GO:0050995 | negative regulation of lipid catabolic process | 4.802686e-9 |
GO:0072109 | glomerular mesangium development | 7.903130e-9 |
GO:0033700 | phospholipid efflux | 1.924874e-8 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 3.350188e-8 |
GO:0007522 | visceral muscle development | 4.201374e-8 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 5.166701e-8 |
GO:0034382 | chylomicron remnant clearance | 5.166701e-8 |
GO:0031331 | positive regulation of cellular catabolic process | 5.436244e-8 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 5.495782e-8 |
GO:0042304 | regulation of fatty acid biosynthetic process | 7.902019e-8 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 1.070520e-7 |
GO:0071071 | regulation of phospholipid biosynthetic process | 1.092978e-7 |
GO:0009082 | branched chain family amino acid biosynthetic process | 1.447139e-7 |
GO:0033344 | cholesterol efflux | 1.451982e-7 |
GO:0032365 | intracellular lipid transport | 1.459824e-7 |
GO:0043462 | regulation of ATPase activity | 1.577567e-7 |
GO:0050994 | regulation of lipid catabolic process | 1.624089e-7 |
GO:0046890 | regulation of lipid biosynthetic process | 1.673787e-7 |
GO:0045833 | negative regulation of lipid metabolic process | 2.023181e-7 |
GO:0090192 | regulation of glomerulus development | 2.890749e-7 |
GO:0050779 | RNA destabilization | 3.130622e-7 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 7.817280e-7 |
GO:0010897 | negative regulation of triglyceride catabolic process | 7.817280e-7 |
GO:0048246 | macrophage chemotaxis | 1.205814e-6 |
GO:0045862 | positive regulation of proteolysis | 1.272901e-6 |
GO:0071316 | cellular response to nicotine | 1.495216e-6 |
GO:0002439 | chronic inflammatory response to antigenic stimulus | 1.495216e-6 |
GO:0002036 | regulation of L-glutamate transport | 1.829964e-6 |
GO:0072044 | collecting duct development | 1.848326e-6 |
GO:0032367 | intracellular cholesterol transport | 1.954666e-6 |
GO:0051956 | negative regulation of amino acid transport | 2.453188e-6 |
GO:0072144 | glomerular mesangial cell development | 2.576414e-6 |
GO:0009948 | anterior/posterior axis specification | 2.622105e-6 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 2.757814e-6 |
GO:0030049 | muscle filament sliding | 3.646989e-6 |
GO:0048484 | enteric nervous system development | 3.789361e-6 |
GO:0060621 | negative regulation of cholesterol import | 4.282685e-6 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 4.308562e-6 |
GO:0010770 | positive regulation of cell morphogenesis involved in differentiation | 4.342638e-6 |
GO:0003219 | cardiac right ventricle formation | 4.732655e-6 |
GO:0032049 | cardiolipin biosynthetic process | 4.928574e-6 |
GO:0008595 | anterior/posterior axis specification, embryo | 5.959820e-6 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.129187e-6 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 7.138254e-6 |
GO:0003229 | ventricular cardiac muscle tissue development | 7.322252e-6 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 7.441806e-6 |
GO:0002268 | follicular dendritic cell differentiation | 7.554470e-6 |
GO:0072215 | regulation of metanephros development | 8.127862e-6 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 8.526748e-6 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 8.614014e-6 |
GO:0031329 | regulation of cellular catabolic process | 1.017985e-5 |
GO:0070328 | triglyceride homeostasis | 1.033972e-5 |
GO:0090183 | regulation of kidney development | 1.041919e-5 |
GO:0007422 | peripheral nervous system development | 1.050699e-5 |
GO:0048739 | cardiac muscle fiber development | 1.109639e-5 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.249241e-5 |
GO:0072110 | glomerular mesangial cell proliferation | 1.284984e-5 |
GO:0061046 | regulation of branching involved in lung morphogenesis | 1.293847e-5 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.299404e-5 |
GO:0051055 | negative regulation of lipid biosynthetic process | 1.339906e-5 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 1.427714e-5 |
GO:0045994 | positive regulation of translational initiation by iron | 1.427714e-5 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 1.427714e-5 |
GO:0002037 | negative regulation of L-glutamate transport | 1.427714e-5 |
GO:0035441 | cell migration involved in vasculogenesis | 1.653044e-5 |
GO:0007386 | compartment pattern specification | 1.798941e-5 |
GO:0045930 | negative regulation of mitotic cell cycle | 1.828339e-5 |
GO:0043691 | reverse cholesterol transport | 1.868286e-5 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 2.062169e-5 |
GO:0044240 | multicellular organismal lipid catabolic process | 2.118406e-5 |
GO:0061014 | positive regulation of mRNA catabolic process | 2.194521e-5 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 2.251049e-5 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 2.305876e-5 |
GO:0072143 | mesangial cell development | 2.332292e-5 |
GO:0060033 | anatomical structure regression | 2.362322e-5 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 2.389644e-5 |
GO:0003002 | regionalization | 2.414955e-5 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 2.729086e-5 |
GO:0048261 | negative regulation of receptor-mediated endocytosis | 2.817474e-5 |
GO:0032571 | response to vitamin K | 3.009323e-5 |
GO:0090102 | cochlea development | 3.387804e-5 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 3.400589e-5 |
GO:0071333 | cellular response to glucose stimulus | 3.421667e-5 |
GO:0046580 | negative regulation of Ras protein signal transduction | 3.447172e-5 |
GO:0001678 | cellular glucose homeostasis | 3.455592e-5 |
GO:0003156 | regulation of organ formation | 3.465490e-5 |
GO:0033088 | negative regulation of immature T cell proliferation in thymus | 3.476044e-5 |
GO:0034447 | very-low-density lipoprotein particle clearance | 3.504981e-5 |
GO:0006863 | purine base transport | 3.708139e-5 |
GO:0045792 | negative regulation of cell size | 4.210709e-5 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 4.308299e-5 |
GO:0006817 | phosphate ion transport | 4.324865e-5 |
GO:0000305 | response to oxygen radical | 4.457983e-5 |
GO:0065005 | protein-lipid complex assembly | 4.488445e-5 |
GO:0014015 | positive regulation of gliogenesis | 4.595308e-5 |
GO:0006474 | N-terminal protein amino acid acetylation | 5.084515e-5 |
GO:0031440 | regulation of mRNA 3'-end processing | 5.614496e-5 |
GO:0010901 | regulation of very-low-density lipoprotein particle remodeling | 6.266925e-5 |
GO:0071300 | cellular response to retinoic acid | 6.418812e-5 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 6.425757e-5 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 6.545441e-5 |
GO:0010984 | regulation of lipoprotein particle clearance | 6.696420e-5 |
GO:0033083 | regulation of immature T cell proliferation | 6.844657e-5 |
GO:0071322 | cellular response to carbohydrate stimulus | 7.033932e-5 |
GO:0015802 | basic amino acid transport | 7.110578e-5 |
GO:0019048 | virus-host interaction | 7.839204e-5 |
GO:0060688 | regulation of morphogenesis of a branching structure | 8.377078e-5 |
GO:0045618 | positive regulation of keratinocyte differentiation | 8.537611e-5 |
GO:0072074 | kidney mesenchyme development | 8.595409e-5 |
GO:0072012 | glomerulus vasculature development | 8.937870e-5 |
GO:0003205 | cardiac chamber development | 9.356281e-5 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 9.946720e-5 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.022955e-4 |
GO:0071422 | succinate transmembrane transport | 1.035364e-4 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.040421e-4 |
GO:0006558 | L-phenylalanine metabolic process | 1.049157e-4 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.064722e-4 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 1.080793e-4 |
GO:0032048 | cardiolipin metabolic process | 1.082246e-4 |
GO:0090103 | cochlea morphogenesis | 1.155013e-4 |
GO:0003206 | cardiac chamber morphogenesis | 1.155149e-4 |
GO:0042267 | natural killer cell mediated cytotoxicity | 1.164408e-4 |
GO:0071299 | cellular response to vitamin A | 1.216585e-4 |
GO:0060620 | regulation of cholesterol import | 1.233597e-4 |
GO:0010823 | negative regulation of mitochondrion organization | 1.363631e-4 |
GO:0060026 | convergent extension | 1.372722e-4 |
GO:0003209 | cardiac atrium morphogenesis | 1.396748e-4 |
GO:0001710 | mesodermal cell fate commitment | 1.414126e-4 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.437739e-4 |
GO:0000271 | polysaccharide biosynthetic process | 1.451268e-4 |
GO:0014829 | vascular smooth muscle contraction | 1.477968e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.485779e-4 |
GO:0045055 | regulated secretory pathway | 1.551705e-4 |
GO:0061013 | regulation of mRNA catabolic process | 1.557000e-4 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 1.678667e-4 |
GO:0048332 | mesoderm morphogenesis | 1.700224e-4 |
GO:0043587 | tongue morphogenesis | 1.725758e-4 |
GO:0045940 | positive regulation of steroid metabolic process | 1.736608e-4 |
GO:0071529 | cementum mineralization | 1.895783e-4 |
GO:0034369 | plasma lipoprotein particle remodeling | 1.932198e-4 |
GO:0009103 | lipopolysaccharide biosynthetic process | 1.937953e-4 |
GO:0001885 | endothelial cell development | 1.976251e-4 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.989601e-4 |
GO:0014037 | Schwann cell differentiation | 2.038650e-4 |
GO:0007501 | mesodermal cell fate specification | 2.176942e-4 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 2.239215e-4 |
GO:0002221 | pattern recognition receptor signaling pathway | 2.315789e-4 |
GO:0032375 | negative regulation of cholesterol transport | 2.319231e-4 |
GO:0072015 | glomerular visceral epithelial cell development | 2.457769e-4 |
GO:0006559 | L-phenylalanine catabolic process | 2.457769e-4 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 2.505626e-4 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.505626e-4 |
GO:0000185 | activation of MAPKKK activity | 2.630672e-4 |
GO:0003231 | cardiac ventricle development | 2.745925e-4 |
GO:0014044 | Schwann cell development | 2.772705e-4 |
GO:0071803 | positive regulation of podosome assembly | 3.041861e-4 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 3.041861e-4 |
GO:0042363 | fat-soluble vitamin catabolic process | 3.041861e-4 |
GO:0034375 | high-density lipoprotein particle remodeling | 3.111791e-4 |
GO:0006656 | phosphatidylcholine biosynthetic process | 3.119589e-4 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 3.139016e-4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 3.148204e-4 |
GO:0045922 | negative regulation of fatty acid metabolic process | 3.149936e-4 |
GO:0014040 | positive regulation of Schwann cell differentiation | 3.151271e-4 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 3.151271e-4 |
GO:0033239 | negative regulation of cellular amine metabolic process | 3.191560e-4 |
GO:0060696 | regulation of phospholipid catabolic process | 3.196310e-4 |
GO:0021515 | cell differentiation in spinal cord | 3.234564e-4 |
GO:0003230 | cardiac atrium development | 3.234564e-4 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.358494e-4 |
GO:0002739 | regulation of cytokine secretion involved in immune response | 3.380410e-4 |
GO:0045687 | positive regulation of glial cell differentiation | 3.525504e-4 |
GO:0014824 | artery smooth muscle contraction | 3.538269e-4 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 3.538269e-4 |
GO:0048012 | hepatocyte growth factor receptor signaling pathway | 3.547358e-4 |
GO:0042149 | cellular response to glucose starvation | 3.560979e-4 |
GO:0046470 | phosphatidylcholine metabolic process | 3.570336e-4 |
GO:0003215 | cardiac right ventricle morphogenesis | 3.713993e-4 |
GO:0072017 | distal tubule development | 3.777078e-4 |
GO:0030421 | defecation | 3.820859e-4 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 3.857914e-4 |
GO:0001886 | endothelial cell morphogenesis | 3.857914e-4 |
GO:0032148 | activation of protein kinase B activity | 3.857914e-4 |
GO:0002227 | innate immune response in mucosa | 3.884424e-4 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 3.976959e-4 |
GO:0043299 | leukocyte degranulation | 4.044635e-4 |
GO:0060744 | mammary gland branching involved in thelarche | 4.075129e-4 |
GO:0060070 | canonical Wnt receptor signaling pathway | 4.115246e-4 |
GO:0045073 | regulation of chemokine biosynthetic process | 4.214104e-4 |
GO:0021904 | dorsal/ventral neural tube patterning | 4.244712e-4 |
GO:0060923 | cardiac muscle cell fate commitment | 4.341732e-4 |
GO:0043491 | protein kinase B signaling cascade | 4.468114e-4 |
GO:0010896 | regulation of triglyceride catabolic process | 4.485759e-4 |
GO:0072111 | cell proliferation involved in kidney development | 4.728143e-4 |
GO:0003208 | cardiac ventricle morphogenesis | 4.771270e-4 |
GO:0046022 | positive regulation of transcription from RNA polymerase II promoter during mitosis | 4.810692e-4 |
GO:0032321 | positive regulation of Rho GTPase activity | 4.911806e-4 |
GO:0002740 | negative regulation of cytokine secretion involved in immune response | 4.997527e-4 |
GO:0042373 | vitamin K metabolic process | 5.027465e-4 |
GO:0003270 | Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation | 5.049752e-4 |
GO:0014807 | regulation of somitogenesis | 5.049752e-4 |
GO:0072298 | regulation of metanephric glomerulus development | 5.158208e-4 |
GO:0032495 | response to muramyl dipeptide | 5.162486e-4 |
GO:0060638 | mesenchymal-epithelial cell signaling | 5.164347e-4 |
GO:0006546 | glycine catabolic process | 5.328019e-4 |
GO:0009894 | regulation of catabolic process | 5.428051e-4 |
GO:0002758 | innate immune response-activating signal transduction | 5.435241e-4 |
GO:0006982 | response to lipid hydroperoxide | 5.620935e-4 |
GO:0051323 | metaphase | 5.620935e-4 |
GO:0006171 | cAMP biosynthetic process | 5.693588e-4 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 5.756904e-4 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 6.483792e-4 |
GO:0015760 | glucose-6-phosphate transport | 6.483792e-4 |
GO:0071827 | plasma lipoprotein particle organization | 6.600891e-4 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 6.749905e-4 |
GO:0072205 | metanephric collecting duct development | 7.117528e-4 |
GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 7.298368e-4 |
GO:0043031 | negative regulation of macrophage activation | 7.298368e-4 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 7.405257e-4 |
GO:0050935 | iridophore differentiation | 7.405257e-4 |
GO:0072284 | metanephric S-shaped body morphogenesis | 7.405257e-4 |
GO:0048937 | lateral line nerve glial cell development | 7.405257e-4 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 7.405257e-4 |
GO:0009098 | leucine biosynthetic process | 8.104052e-4 |
GO:0035674 | tricarboxylic acid transmembrane transport | 8.104052e-4 |
GO:0006550 | isoleucine catabolic process | 8.104052e-4 |
GO:0032319 | regulation of Rho GTPase activity | 8.116091e-4 |
GO:0010900 | negative regulation of phosphatidylcholine catabolic process | 8.127756e-4 |
GO:0060675 | ureteric bud morphogenesis | 8.241127e-4 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 8.323203e-4 |
GO:0051156 | glucose 6-phosphate metabolic process | 8.323203e-4 |
GO:0006867 | asparagine transport | 8.323203e-4 |
GO:0001823 | mesonephros development | 8.415224e-4 |
GO:0021681 | cerebellar granular layer development | 8.491736e-4 |
GO:2000826 | regulation of heart morphogenesis | 8.647140e-4 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 9.147928e-4 |
GO:0051639 | actin filament network formation | 9.147928e-4 |
GO:0034653 | retinoic acid catabolic process | 9.147928e-4 |
GO:0033590 | response to cobalamin | 9.170496e-4 |
GO:0045581 | negative regulation of T cell differentiation | 9.442611e-4 |
GO:0061136 | regulation of proteasomal protein catabolic process | 9.503829e-4 |
GO:0009584 | detection of visible light | 9.565297e-4 |
GO:0000089 | mitotic metaphase | 9.732362e-4 |
GO:2000194 | regulation of female gonad development | 9.735108e-4 |
GO:0061311 | cell surface receptor linked signaling pathway involved in heart development | 9.808270e-4 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 9.848768e-4 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 9.848768e-4 |
GO:0007356 | thorax and anterior abdomen determination | 9.848768e-4 |
GO:0006189 | 'de novo' IMP biosynthetic process | 9.848768e-4 |
GO:2000027 | regulation of organ morphogenesis | 9.897511e-4 |
GO:0015747 | urate transport | 1.031849e-3 |
GO:0030300 | regulation of intestinal cholesterol absorption | 1.040983e-3 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 1.045461e-3 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 1.052309e-3 |
GO:0072179 | nephric duct formation | 1.062898e-3 |
GO:0043154 | negative regulation of caspase activity | 1.131938e-3 |
GO:0030513 | positive regulation of BMP signaling pathway | 1.142607e-3 |
GO:0045103 | intermediate filament-based process | 1.142607e-3 |
GO:2000195 | negative regulation of female gonad development | 1.161841e-3 |
GO:0045955 | negative regulation of calcium ion-dependent exocytosis | 1.161841e-3 |
GO:0050685 | positive regulation of mRNA processing | 1.179512e-3 |
GO:0010801 | negative regulation of peptidyl-threonine phosphorylation | 1.197871e-3 |
GO:0055090 | acylglycerol homeostasis | 1.197871e-3 |
GO:0001667 | ameboidal cell migration | 1.199600e-3 |
GO:0044341 | sodium-dependent phosphate transport | 1.237870e-3 |
GO:0048706 | embryonic skeletal system development | 1.238503e-3 |
GO:0030301 | cholesterol transport | 1.249639e-3 |
GO:0034505 | tooth mineralization | 1.264263e-3 |
GO:0042593 | glucose homeostasis | 1.328469e-3 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 1.361383e-3 |
GO:0071506 | cellular response to mycophenolic acid | 1.361383e-3 |
GO:0045218 | zonula adherens maintenance | 1.361383e-3 |
GO:0050917 | sensory perception of umami taste | 1.361383e-3 |
GO:0072011 | glomerular endothelium development | 1.387850e-3 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.387850e-3 |
GO:0050823 | peptide antigen stabilization | 1.387850e-3 |
GO:0045980 | negative regulation of nucleotide metabolic process | 1.402796e-3 |
GO:0030509 | BMP signaling pathway | 1.423881e-3 |
GO:0019430 | removal of superoxide radicals | 1.444535e-3 |
GO:0034101 | erythrocyte homeostasis | 1.470330e-3 |
GO:0030198 | extracellular matrix organization | 1.477598e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 1.484627e-3 |
GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus | 1.523178e-3 |
GO:0035645 | enteric smooth muscle cell differentiation | 1.523178e-3 |
GO:0007497 | posterior midgut development | 1.523178e-3 |
GO:0090184 | positive regulation of kidney development | 1.532011e-3 |
GO:0070245 | positive regulation of thymocyte apoptosis | 1.532011e-3 |
GO:0010948 | negative regulation of cell cycle process | 1.571289e-3 |
GO:0052200 | response to host defenses | 1.576184e-3 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 1.589895e-3 |
GO:0008203 | cholesterol metabolic process | 1.623686e-3 |
GO:0000303 | response to superoxide | 1.638492e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.651389e-3 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 1.651389e-3 |
GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1.661980e-3 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 1.661980e-3 |
GO:0002275 | myeloid cell activation involved in immune response | 1.691066e-3 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1.718452e-3 |
GO:0015851 | nucleobase transport | 1.721568e-3 |
GO:0090086 | negative regulation of protein deubiquitination | 1.722607e-3 |
GO:0050655 | dermatan sulfate proteoglycan metabolic process | 1.722607e-3 |
GO:0009642 | response to light intensity | 1.722607e-3 |
GO:0097006 | regulation of plasma lipoprotein particle levels | 1.741667e-3 |
GO:0032374 | regulation of cholesterol transport | 1.741837e-3 |
GO:0070243 | regulation of thymocyte apoptosis | 1.748341e-3 |
GO:0070234 | positive regulation of T cell apoptosis | 1.750080e-3 |
GO:0001570 | vasculogenesis | 1.751433e-3 |
GO:0035372 | protein localization to microtubule | 1.785446e-3 |
GO:0007140 | male meiosis | 1.829635e-3 |
GO:0048754 | branching morphogenesis of a tube | 1.842020e-3 |
GO:0006572 | tyrosine catabolic process | 1.851328e-3 |
GO:0090218 | positive regulation of lipid kinase activity | 1.875351e-3 |
GO:0001829 | trophectodermal cell differentiation | 1.926751e-3 |
GO:0060065 | uterus development | 1.991700e-3 |
GO:0016125 | sterol metabolic process | 2.053412e-3 |
GO:0046849 | bone remodeling | 2.074883e-3 |
GO:2000573 | positive regulation of DNA biosynthetic process | 2.139649e-3 |
GO:0045662 | negative regulation of myoblast differentiation | 2.145039e-3 |
GO:0033692 | cellular polysaccharide biosynthetic process | 2.192490e-3 |
GO:0045921 | positive regulation of exocytosis | 2.194994e-3 |
GO:0003222 | ventricular trabecular myocardium morphogenesis | 2.210436e-3 |
GO:0031536 | positive regulation of exit from mitosis | 2.246771e-3 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 2.261133e-3 |
GO:0007440 | foregut morphogenesis | 2.263090e-3 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 2.278726e-3 |
GO:0001755 | neural crest cell migration | 2.328639e-3 |
GO:0044058 | regulation of digestive system process | 2.339373e-3 |
GO:0072203 | cell proliferation involved in metanephros development | 2.359799e-3 |
GO:0010656 | negative regulation of muscle cell apoptosis | 2.365962e-3 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 2.366046e-3 |
GO:0046039 | GTP metabolic process | 2.385586e-3 |
GO:0071257 | cellular response to electrical stimulus | 2.388190e-3 |
GO:0045104 | intermediate filament cytoskeleton organization | 2.395717e-3 |
GO:0032488 | Cdc42 protein signal transduction | 2.409389e-3 |
GO:0032862 | activation of Rho GTPase activity | 2.481274e-3 |
GO:0000578 | embryonic axis specification | 2.494244e-3 |
GO:0045834 | positive regulation of lipid metabolic process | 2.531171e-3 |
GO:0045684 | positive regulation of epidermis development | 2.543602e-3 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 2.552004e-3 |
GO:0031581 | hemidesmosome assembly | 2.557359e-3 |
GO:0022011 | myelination in peripheral nervous system | 2.557359e-3 |
GO:0072498 | embryonic skeletal joint development | 2.571930e-3 |
GO:0006405 | RNA export from nucleus | 2.572152e-3 |
GO:0000060 | protein import into nucleus, translocation | 2.572152e-3 |
GO:0061077 | chaperone-mediated protein folding | 2.577245e-3 |
GO:0015809 | arginine transport | 2.607096e-3 |
GO:0060981 | cell migration involved in coronary angiogenesis | 2.625565e-3 |
GO:0071670 | smooth muscle cell chemotaxis | 2.625565e-3 |
GO:0051725 | protein de-ADP-ribosylation | 2.625565e-3 |
GO:0002224 | toll-like receptor signaling pathway | 2.671864e-3 |
GO:0072112 | glomerular visceral epithelial cell differentiation | 2.684646e-3 |
GO:0006927 | transformed cell apoptosis | 2.712799e-3 |
GO:0042274 | ribosomal small subunit biogenesis | 2.719687e-3 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 2.762418e-3 |
GO:0046487 | glyoxylate metabolic process | 2.794999e-3 |
GO:0032682 | negative regulation of chemokine production | 2.794999e-3 |
GO:0009896 | positive regulation of catabolic process | 2.804289e-3 |
GO:0042415 | norepinephrine metabolic process | 2.834285e-3 |
GO:0090209 | negative regulation of triglyceride metabolic process | 2.892053e-3 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 2.942967e-3 |
GO:0010159 | specification of organ position | 2.942967e-3 |
GO:0032012 | regulation of ARF protein signal transduction | 2.957921e-3 |
GO:0007141 | male meiosis I | 2.959312e-3 |
GO:0010288 | response to lead ion | 2.973776e-3 |
GO:0035520 | monoubiquitinated protein deubiquitination | 2.988565e-3 |
GO:0071460 | cellular response to cell-matrix adhesion | 2.988565e-3 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 2.988565e-3 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 2.990217e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 2.990217e-3 |
GO:0050651 | dermatan sulfate proteoglycan biosynthetic process | 2.990217e-3 |
GO:0015746 | citrate transport | 2.990217e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 2.990217e-3 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 2.990217e-3 |
GO:0033591 | response to L-ascorbic acid | 3.022280e-3 |
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 3.024151e-3 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 3.028531e-3 |
GO:0051090 | regulation of sequence-specific DNA binding transcription factor activity | 3.048548e-3 |
GO:0030218 | erythrocyte differentiation | 3.095186e-3 |
GO:0001707 | mesoderm formation | 3.098984e-3 |
GO:0035306 | positive regulation of dephosphorylation | 3.102564e-3 |
GO:0021871 | forebrain regionalization | 3.148087e-3 |
GO:0060272 | embryonic skeletal joint morphogenesis | 3.148962e-3 |
GO:0009952 | anterior/posterior pattern specification | 3.168810e-3 |
GO:0034442 | regulation of lipoprotein oxidation | 3.298127e-3 |
GO:0072006 | nephron development | 3.354398e-3 |
GO:0042703 | menstruation | 3.365060e-3 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 3.365060e-3 |
GO:0019101 | female somatic sex determination | 3.365060e-3 |
GO:0060299 | negative regulation of sarcomere organization | 3.365060e-3 |
GO:0001579 | medium-chain fatty acid transport | 3.365060e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 3.365060e-3 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 3.365060e-3 |
GO:0006285 | base-excision repair, AP site formation | 3.365060e-3 |
GO:0043586 | tongue development | 3.397181e-3 |
GO:0030865 | cortical cytoskeleton organization | 3.469275e-3 |
GO:0060037 | pharyngeal system development | 3.472475e-3 |
GO:0046855 | inositol phosphate dephosphorylation | 3.483934e-3 |
GO:0072178 | nephric duct morphogenesis | 3.507972e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 3.507972e-3 |
GO:0060686 | negative regulation of prostatic bud formation | 3.629638e-3 |
GO:0050908 | detection of light stimulus involved in visual perception | 3.629638e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 3.636766e-3 |
GO:0071044 | histone mRNA catabolic process | 3.671855e-3 |
GO:0010893 | positive regulation of steroid biosynthetic process | 3.699339e-3 |
GO:0030219 | megakaryocyte differentiation | 3.763582e-3 |
GO:0061138 | morphogenesis of a branching epithelium | 3.812144e-3 |
GO:0016032 | viral reproduction | 3.927503e-3 |
GO:0006415 | translational termination | 3.947202e-3 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 3.962033e-3 |
GO:0002115 | store-operated calcium entry | 3.962033e-3 |
GO:0035307 | positive regulation of protein dephosphorylation | 4.001367e-3 |
GO:0060685 | regulation of prostatic bud formation | 4.020744e-3 |
GO:0051450 | myoblast proliferation | 4.020744e-3 |
GO:0007498 | mesoderm development | 4.052281e-3 |
GO:0009895 | negative regulation of catabolic process | 4.053470e-3 |
GO:0001763 | morphogenesis of a branching structure | 4.063056e-3 |
GO:0048793 | pronephros development | 4.063395e-3 |
GO:0045620 | negative regulation of lymphocyte differentiation | 4.074561e-3 |
GO:0031034 | myosin filament assembly | 4.088620e-3 |
GO:0007216 | metabotropic glutamate receptor signaling pathway | 4.114340e-3 |
GO:0051148 | negative regulation of muscle cell differentiation | 4.383614e-3 |
GO:0051588 | regulation of neurotransmitter transport | 4.435470e-3 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 4.450080e-3 |
GO:0060485 | mesenchyme development | 4.470422e-3 |
GO:0061097 | regulation of protein tyrosine kinase activity | 4.479915e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 4.480598e-3 |
GO:0002385 | mucosal immune response | 4.494794e-3 |
GO:0060029 | convergent extension involved in organogenesis | 4.576706e-3 |
GO:0018106 | peptidyl-histidine phosphorylation | 4.610742e-3 |
GO:0003266 | regulation of secondary heart field cardioblast proliferation | 4.644568e-3 |
GO:0015914 | phospholipid transport | 4.660291e-3 |
GO:0031639 | plasminogen activation | 4.749820e-3 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 4.749820e-3 |
GO:0006603 | phosphocreatine metabolic process | 4.749820e-3 |
GO:0060710 | chorio-allantoic fusion | 4.847111e-3 |
GO:0007044 | cell-substrate junction assembly | 4.847710e-3 |
GO:0072050 | S-shaped body morphogenesis | 4.855479e-3 |
GO:0060707 | trophoblast giant cell differentiation | 4.855479e-3 |
GO:0072049 | comma-shaped body morphogenesis | 4.855479e-3 |
GO:0035104 | positive regulation of transcription via sterol regulatory element binding | 4.864934e-3 |
GO:0019853 | L-ascorbic acid biosynthetic process | 4.896762e-3 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 4.937499e-3 |
GO:0072255 | metanephric glomerular mesangial cell development | 4.937499e-3 |
GO:0045064 | T-helper 2 cell differentiation | 4.937499e-3 |
GO:0072264 | metanephric glomerular endothelium development | 4.937499e-3 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 4.937499e-3 |
GO:0003104 | positive regulation of glomerular filtration | 4.937499e-3 |
GO:0038001 | paracrine signaling | 4.937499e-3 |
GO:0008065 | establishment of blood-nerve barrier | 4.937499e-3 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 4.937499e-3 |
GO:0009190 | cyclic nucleotide biosynthetic process | 4.997507e-3 |
GO:0000460 | maturation of 5.8S rRNA | 5.004257e-3 |
GO:0033147 | negative regulation of estrogen receptor signaling pathway | 5.012188e-3 |
GO:0019049 | evasion of host defenses by virus | 5.012188e-3 |
GO:0034377 | plasma lipoprotein particle assembly | 5.042756e-3 |
GO:0060976 | coronary vasculature development | 5.065245e-3 |
GO:0021978 | telencephalon regionalization | 5.114157e-3 |
GO:0010872 | regulation of cholesterol esterification | 5.126734e-3 |
GO:0072075 | metanephric mesenchyme development | 5.136115e-3 |
GO:0072198 | mesenchymal cell proliferation involved in ureter development | 5.138324e-3 |
GO:0072101 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway | 5.138324e-3 |
GO:0072200 | negative regulation of mesenchymal cell proliferation involved in ureter development | 5.138324e-3 |
GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development | 5.138324e-3 |
GO:0072192 | ureter epithelial cell differentiation | 5.138324e-3 |
GO:2000007 | negative regulation of metanephric comma-shaped body morphogenesis | 5.138324e-3 |
GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis | 5.138324e-3 |
GO:2000005 | negative regulation of metanephric S-shaped body morphogenesis | 5.138324e-3 |
GO:0090194 | negative regulation of glomerulus development | 5.138324e-3 |
GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis | 5.138324e-3 |
GO:0061151 | BMP signaling pathway involved in renal system segmentation | 5.138324e-3 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 5.138324e-3 |
GO:0048392 | intermediate mesodermal cell differentiation | 5.138324e-3 |
GO:0007500 | mesodermal cell fate determination | 5.138324e-3 |
GO:0072097 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway | 5.138324e-3 |
GO:0060502 | epithelial cell proliferation involved in lung morphogenesis | 5.138324e-3 |
GO:0055020 | positive regulation of cardiac muscle fiber development | 5.138324e-3 |
GO:0071893 | BMP signaling pathway involved in nephric duct formation | 5.138324e-3 |
GO:0061149 | BMP signaling pathway involved in ureter morphogenesis | 5.138324e-3 |
GO:0061155 | pulmonary artery endothelial tube morphogenesis | 5.138324e-3 |
GO:0060503 | bud dilation involved in lung branching | 5.138324e-3 |
GO:0090193 | positive regulation of glomerulus development | 5.317650e-3 |
GO:0048568 | embryonic organ development | 5.335610e-3 |
GO:0032472 | Golgi calcium ion transport | 5.335933e-3 |
GO:0032468 | Golgi calcium ion homeostasis | 5.335933e-3 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 5.335933e-3 |
GO:0031296 | B cell costimulation | 5.335933e-3 |
GO:0030026 | cellular manganese ion homeostasis | 5.335933e-3 |
GO:0034381 | plasma lipoprotein particle clearance | 5.340879e-3 |
GO:0033081 | regulation of T cell differentiation in thymus | 5.376337e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 5.452581e-3 |
GO:0048340 | paraxial mesoderm morphogenesis | 5.452581e-3 |
GO:0006184 | GTP catabolic process | 5.490093e-3 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 5.502482e-3 |
GO:0035304 | regulation of protein dephosphorylation | 5.514710e-3 |
GO:0007614 | short-term memory | 5.514886e-3 |
GO:0006406 | mRNA export from nucleus | 5.529917e-3 |
GO:0048251 | elastic fiber assembly | 5.535906e-3 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 5.536575e-3 |
GO:0071294 | cellular response to zinc ion | 5.536575e-3 |